| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,273,397 |
|
|
|
Indirect Value
|
$265,218 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$23,538,615 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
AS |
$686.00 |
$56,938 |
D/D |
(83) |
28,877 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-02 |
4 |
AS |
$495.24 |
$52,068 |
D/D |
(105) |
25,056 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-13 |
4 |
AS |
$398.63 |
$42,806 |
D/D |
(107) |
24,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-13 |
4 |
AS |
$662.50 |
$76,850 |
D/D |
(116) |
29,260 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-27 |
4 |
AS |
$819.47 |
$150,372 |
D/D |
(183) |
32,929 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-05 |
4 |
AS |
$500.33 |
$94,700 |
D/D |
(189) |
7,573 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-26 |
4 |
AS |
$452.04 |
$91,242 |
D/D |
(200) |
24,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-25 |
4 |
AS |
$438.00 |
$96,088 |
D/D |
(214) |
25,173 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-08-23 |
4 |
S |
$844.00 |
$188,212 |
D/D |
(223) |
31,699 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-02-02 |
4 |
D |
$956.65 |
$268,819 |
D/D |
(281) |
23,693 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-31 |
4 |
D |
$953.42 |
$268,864 |
D/D |
(282) |
23,574 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
D |
$682.50 |
$195,195 |
D/D |
(286) |
28,956 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-16 |
4 |
AS |
$677.00 |
$203,100 |
D/D |
(300) |
28,960 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
AS |
$693.00 |
$207,900 |
D/D |
(300) |
28,656 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
D |
$691.31 |
$215,689 |
D/D |
(312) |
28,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-01 |
4 |
AS |
$695.50 |
$219,875 |
D/D |
(316) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-08 |
4 |
AS |
$724.33 |
$239,780 |
D/D |
(325) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-04 |
4 |
D |
$917.05 |
$313,631 |
D/D |
(342) |
22,606 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-24 |
4 |
D |
$951.26 |
$334,844 |
D/D |
(352) |
23,456 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-17 |
4 |
D |
$932.34 |
$330,048 |
D/D |
(354) |
22,984 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-17 |
4 |
AS |
$739.50 |
$264,741 |
D/D |
(358) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-09 |
4 |
AS |
$610.85 |
$224,891 |
D/D |
(364) |
25,903 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
OE |
$381.92 |
$139,401 |
D/D |
365 |
29,242 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-21 |
4 |
AS |
$647.50 |
$253,204 |
D/D |
(391) |
24,669 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-12 |
4 |
D |
$402.34 |
$158,120 |
D/D |
(393) |
25,080 |
0 |
- |
|
158 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
